Abbott ranked No. 3 on The Fair360, formerly DiversityInc Top 50 Companies for Diversity list in 2022.
Abbott Laboratories played a leading role in a panel discussion recently titled “The Future of At Home Testing” at the CES 2023 meeting in Las Vegas.
The Consumer Technology Association dubs the event as “the most influential tech event in the world — the proving ground for breakthrough technologies and global innovators.”
The session included Principal Scientist Mary Rodgers, who outlined some of Abbott’s most important efforts around improving at-home tests for a variety of conditions and needs.
“We’d like to be able to offer the right test in the right place for as many people and occasions as possible,” she said. “We want to make sure they’re tailored to the needs that exist and we’re starting to develop tests that we could only have imagined a few years ago.”
Abbott’s diagnostic research played an important part in helping combat COVID-19 during the pandemic through its development of antibody tests. That work continues as the company looks forward to other threats that the world may face in the coming years.
“We don’t want to live through another pandemic like we just had,” Rodgers said. “One of the ways we’re preparing so we can make a difference is partnering with institutions across five continents to form the Abbott Pandemic Defense Coalition. We’re working with these partners to sense and understand which new pathogens might be spreading out there and be part of the response by building prototype tests that can help us answer key public health questions.”
The panel discussion was published on Abbott’s YouTube channel last week. Additional topics include wearable technology, what conditions aren’t a good fit for at-home testing and more.
